Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Zacharioudaki

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Scientific Reports|July 6, 2021
Vitamin D receptor, vitamin D binding protein and CYP27B1 single nucleotide polymorphisms and susceptibility to viral infections in infantsMaria Zacharioudaki, Ippokratis Messaritakis, Emmanouil Galanakis
Infectious Disease Reports|February 24, 2022
Challenges in the Diagnosis of Viral Encephalitis in Children: The Case of Two SiblingsEleni Vergadi, Maria Zacharioudaki, Maria Raissaki, et al.
Skin Health and Disease|June 7, 2024
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panelJonathan N Barker, Gabrielle Becher, David A Burden, et al.
Frontiers in Oncology|September 15, 2025
Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent hormone-sensitive prostate cancer: a network meta-analysisArmen Aprikian, Andrew Chilelli, Thomas McLean, et al.
Diagnostics (Basel, Switzerland)|June 10, 2023
A Retrospective Study of Petros Ioannou, Maria Zacharioudaki, Despoina Spentzouri, et al.
Antioxidants (Basel, Switzerland)|February 4, 2021
Impact of Mycotoxins on Animals' Oxidative StatusAlexandros Mavrommatis, Elisavet Giamouri, Savvina Tavrizelou, et al.
Communications Medicine|December 11, 2024
Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infectionJohn Karlsson Valik, Christian G Giske, Badrul Hasan, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Infectious Diseases and Therapy|May 25, 2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2019
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scientific Reports|July 6, 2021
Vitamin D receptor, vitamin D binding protein and CYP27B1 single nucleotide polymorphisms and susceptibility to viral infections in infantsMaria Zacharioudaki, Ippokratis Messaritakis, Emmanouil Galanakis
Infectious Disease Reports|February 24, 2022
Challenges in the Diagnosis of Viral Encephalitis in Children: The Case of Two SiblingsEleni Vergadi, Maria Zacharioudaki, Maria Raissaki, et al.
Skin Health and Disease|June 7, 2024
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panelJonathan N Barker, Gabrielle Becher, David A Burden, et al.
Frontiers in Oncology|September 15, 2025
Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent hormone-sensitive prostate cancer: a network meta-analysisArmen Aprikian, Andrew Chilelli, Thomas McLean, et al.
Diagnostics (Basel, Switzerland)|June 10, 2023
A Retrospective Study of Petros Ioannou, Maria Zacharioudaki, Despoina Spentzouri, et al.
Antioxidants (Basel, Switzerland)|February 4, 2021
Impact of Mycotoxins on Animals' Oxidative StatusAlexandros Mavrommatis, Elisavet Giamouri, Savvina Tavrizelou, et al.
Communications Medicine|December 11, 2024
Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infectionJohn Karlsson Valik, Christian G Giske, Badrul Hasan, et al.
International Journal of Antimicrobial Agents|November 27, 2019
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre studyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Infectious Diseases and Therapy|May 25, 2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2019
Ceftazidime, Carbapenems, or Piperacillin-tazobactam as Single Definitive Therapy for Pseudomonas aeruginosa Bloodstream Infection: A Multisite Retrospective StudyTanya Babich, Pontus Naucler, John Karlsson Valik, et al.
Pageof 2